Literature DB >> 24997090

A large individual variation in both the infusion rate and the blood concentration of rocuronium necessary for obtain adequate surgical muscle relaxation during total intravenous anesthesia with propofol and remifentanil.

Akira Kajiura1, Osamu Nagata, Yutaka Takizawa, Takeshi Nakatomi, Shiho Kodera, Takanori Murayama.   

Abstract

BACKGROUND: Rocuronium (Rb) is ideal for continuous infusion but has a widely variable duration of action. We investigated the distribution of Rb infusion in a steady state of optimal muscle relaxation and the relationship between the measured and predicted blood Rb concentrations in laparoscopic surgery.
METHODS: Seventeen patients were anesthetized with propofol. Continuous Rb infusion was commenced at 7.5 µg/kg/min from 15 min after an initial Rb injection (0.6 mg/kg) and adjusted every 15 min to keep T1 within 3-10 %. Blood concentration was measured at the first onset of steady state, predicted concentration was calculated pharmacokinetically, and 25 % recovery time was measured. The distribution of the predicted concentration and infusion rate was plotted by histogram, the median value and 95th percentile were calculated, and the relationship between measured and predicted concentrations was analyzed by regression analysis.
RESULTS: The rate during the stable state was 7.3 ± 2.1 µg/kg/min on average, 4 at minimum, 12 at maximum, and 12 at the 95th percentile. The predicted concentration was 1.7 ± 0.5 µg/ml on average, 0.8 at minimum, and 2.9 at maximum. The mean measured concentration was 1.4 ± 0.4 µg/ml. The predicted concentration was proportional to the measured concentration (y = 0.91x, r = 0.475; p < 0.001). A significant linear relationship was observed between the measured concentration and infusion rate (y = 0.64 + 0.11x, r = 0.618; p < 0.05).
CONCLUSION: The measured blood concentration of Rb was comparable to the predicted value. Anesthesiologists can avoid overdose and attain a reliable muscle relaxant effect by maintaining a continuous dose by titration according to individual differences under muscle relaxant monitoring.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24997090     DOI: 10.1007/s00540-014-1879-6

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  5 in total

1.  The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl.

Authors:  J M Wierda; U W Kleef; L M Lambalk; W D Kloppenburg; S Agoston
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

2.  [Effects of sevoflurane and propofol on neuromuscular blocking action of Org 9426 (rocuronium bromide) infused continuously in Japanese patients].

Authors:  Syunichi Takagi; Makoto Ozaki; Hiroshi Iwasaki; Yoshio Hatano; Junzo Takeda
Journal:  Masui       Date:  2006-08

3.  Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia.

Authors:  E P McCoy; R K Mirakhur; V R Maddineni; J M Wierda; J H Proost
Journal:  Br J Anaesth       Date:  1996-01       Impact factor: 9.166

4.  [Estimated blood concentration of rocuronium administrated by continuous infusion to maintain an appropriate neuromuscular blockade under propofol anesthesia].

Authors:  Sachiko Ito; Osamu Nagata; Makoto Ozaki
Journal:  Masui       Date:  2010-01

5.  Comparison of rocuronium, succinylcholine, and vecuronium for rapid-sequence induction of anesthesia in adult patients.

Authors:  T Magorian; K B Flannery; R D Miller
Journal:  Anesthesiology       Date:  1993-11       Impact factor: 7.892

  5 in total
  2 in total

1.  The Pringle maneuver reduces the infusion rate of rocuronium required to maintain surgical muscle relaxation during hepatectomy.

Authors:  Akira Kajiura; Osamu Nagata; Masamitsu Sanui
Journal:  J Anesth       Date:  2018-04-27       Impact factor: 2.078

2.  Rocuronium bromide: clinical application of single-dose pharmacokinetic models to continuous infusion.

Authors:  Yutaka Oda
Journal:  J Anesth       Date:  2017-08-21       Impact factor: 2.078

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.